Candriam SCA’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $17.9M | Buy |
|
|||||
|
2024
Q3 | $12M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.67M | Hold |
|
|||||
|
2022
Q2 | $2.05M | Hold |
|
|||||
|
2022
Q1 | $2.2M | Sell |
|
|||||
|
2021
Q4 | $6.16M | Sell |
|
|||||
|
2021
Q3 | $18.1M | Buy |
|
|||||
|
2021
Q2 | $13M | Sell |
|
|||||
|
2021
Q1 | $13.9M | Hold |
|
|||||
|
2020
Q4 | $14.5M | Buy |
|
|||||
|
2020
Q3 | $11M | Sell |
|
|||||
|
2020
Q2 | $14.6M | Sell |
|
|||||
|
2020
Q1 | $30M | Hold |
|
|||||
|
2019
Q4 | $30.6M | Sell |
|
|||||
|
2019
Q3 | $6.86M | Buy |
|
|||||
|
2019
Q2 | $6.69M | Sell |
|
|||||
|
2019
Q1 | $8.02M | Buy |
|
|||||
|
2018
Q4 | $7.27M | Buy |
|
|||||
|
2018
Q3 | $11.9M | Buy |
|
|||||
|
2018
Q2 | $4.19M | Buy |
|
|||||
|
2018
Q1 | $4.59M | Sell |
|
|||||
|
2017
Q4 | $4.05M | Buy |
|
|||||
|
2017
Q3 | $2.79M | Buy |
|
|||||
|
2017
Q2 | $1.93M | Sell |
|
|||||
|
2017
Q1 | $3.12M | Buy |
|
|||||
|
2016
Q4 | $1.76M | Buy |
|
|||||
|
2016
Q3 | $1.68M | Sell |
|
|||||
|
2016
Q2 | $8.89M | Buy |
|
|||||
|
2016
Q1 | $3.71M | Sell |
|
|||||
|
2015
Q4 | $7.33M | Buy |
|
|||||
|
2015
Q3 | $4.65M | Sell |
|
|||||
|
2015
Q2 | $5.5M | Buy |
|